Aim The aim of this study was to evaluate and compare the clinical outcomes of vital pulpotomy using biodentine (Septodent, France) or Endocem (Maruchi, Wonju, Korea) as pulp capping materials in a prospective randomized controlled study.
Materials and Methods This study was conducted in 20 subjects who were recruited from patients of the Department of pediatric dentistry of Misr University For science and Technology, Cairo, Egypt. All the patients in this study (10-13 year) were suffering from reversible pulpities in their mature permanent molars, a total of 40 teeth were randomly assigned to either the Biodentin or the Endocem group (20 teeth per group). Vital pulpotomy was done using these 2 materials, and clinical and radiographic evaluations were performed at 6weaks, 6 months, and 1 year follow up period. Teeth with negative response to vitality test and those who exhibit signs of irreversible pulpitis or pulp necrosis were considered as failures.
Results In the 6 weeks, 6months and 1 year follow up, the clinical success rates for the ENDOCEM Zr was 95%. 90% and 90%, respectively and the radiographic success rates were 100%, 90% and 90% respectively. Regarding biodentine pulpotomy, the clinical and radiographic success rate in 6 weeks, 6months and 1 year follow up was 100%, 95% and 95% respectively. The difference between biodentine and MTA groups was statistically non-significant (p = 0.7646>0.05).
Conclusions in this randomized controlled study, Biodentine has clinical and radiograghic success rate comparable to ENDOCEM Zr as a vital pulpotomy in mature permanent molars with carious exposures.